AQR Capital Management - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$85,000
+3.7%
36,787
+243.7%
0.00%
Q3 2019$82,000
-42.7%
10,704
-48.9%
0.00%
Q2 2019$143,000
-37.3%
20,947
-26.0%
0.00%
Q1 2019$228,000
+7.5%
28,2970.0%0.00%
Q4 2018$212,000
-21.8%
28,2970.0%0.00%
Q3 2018$271,000
+28.4%
28,297
+42.0%
0.00%
Q2 2018$211,00019,9210.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Yu Fan 112,044$258,0003.49%
Aisling Capital Management LP 1,691,151$3,890,0002.10%
Sio Capital Management, LLC 871,101$2,004,0000.66%
Bain Capital Life Sciences Investors, LLC 2,847,689$6,550,0000.64%
Samsara BioCapital, LLC 883,720$2,033,0000.51%
Ghost Tree Capital, LLC 686,599$1,579,0000.34%
Nantahala Capital Management 3,200,593$7,361,0000.33%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 245,678$565,0000.29%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,059,894$9,338,0000.28%
Lion Point Capital, LP 300,000$690,0000.16%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders